Informing the drug development and commercialization industry Cary, N.C. – April 23, 2012 – Industry Standard Research (ISR) announced the launch of its 5th annual CRO Quality Benchmarking series with today’s release of its “2013 CRO Quality Benchmarking – Phase II/III Service Providers” report.  The new study surveyed 157 pharmaceutical and biotechnology professionals about their experiences with 29 small, mid-size, and large Phase II/III CROs.  In total, data were collected on 470 service encounters. “Respondents were clear in their praise of DCRI staff, labeling them as industry leaders in ‘therapeutic expertise’ and providing promising feedback across nearly all of the Staff Characteristics measured in this report,” explained Kevin Olson, CEO of Industry Standard Research. “However, respondents do report a narrower range of services from DCRI than others in this category.” In its 5th year, ISR’s CRO Quality Benchmarking series has been designed for the pharmaceutical industry and its service providers: “This report serves as a much needed tool and information resource to ensure that the critical Sponsor/CRO relationship is as productive as possible. By fully understanding each service provider’s Staff, Organizational, and Operational strengths and weaknesses, ISR feels a sponsor can more effectively select service providers that complement its strategy and in-house resources.” In addition to showcasing CRO strengths and weaknesses, the study delivers a detailed analysis of CRO selection drivers, outsourcing volume, preferred CROs, and more.  The report contains 246 pages with over 350 graphs and insightful analysis. CROs included in this analysis: Accenture, Aptiv Solutions, Bioclinica, Charles River, Chiltern, Clinsys, Cognizant, Covance, Davita Clinical Research, DCRI-Duke, Encorium, Eurofins, ICON, INC Research, Medpace, Novella, Paragon, PAREXEL, PharmaNet / i3, PPD, PRA, Premier Research, Quintiles, Rho, RPS, SGS Life Sciences, Tata, Theorem, and Worldwide Clinical Trials. More information about this report is available on ISR’s website at https://isrreports.com/industry-reports/2013-cro-quality-benchmarking-phase-ii_iii-service-providers. About Industry Standard Research Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.

ISR CUSTOMERS